Skip to main content
Caplight Logo









Resonate Forward

Resonate Forward

Private
Hockessin, DelawareHealthcare & Life Scienceshttps://resonateforward.com

Last Round

Grant

Jun 12, 2024

Total Funding Raised

$1.44M

Company Overview

Resonate Forward is a healthcare and life sciences company that develops wearable medical devices designed to reduce symptoms of tremor and freezing of gait in patients with Parkinson's disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

wearable medical deviceParkinson's diseasevibration therapyfreezing of gaittremor managementdigital healthhealth IoTgait analysisnon-invasive therapymovement disordermedtechsmart wearableremote patient monitoringRPMassistive technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Resonate Forward Comparables

Compare Resonate Forward with similar companies based on industry and business-model similarity.

Resonate Forward comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
gaitQ
84%
Charco Neurotech
81%
Walk With Path
81%

Resonate Forward Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 12, 2024
GrantJun 29, 2022
GrantJun 1, 2022
GrantAug 11, 2021
GrantMar 1, 2019

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 12, 2024

    Received grant funding from NIH and NINDS.

  • Jun 29, 2022

    $51K grant received from Startup302

Resonate Forward Filings

Explore SEC and related filing metadata, where available.

Resonate Forward filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Resonate Forward's valuation, stock price, and market status.

Is Resonate Forward a public or private company?

Resonate Forward is a private company.

What is the current stock price of Resonate Forward?

Resonate Forward is a private company with no public stock price. Caplight tracks Resonate Forward's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Resonate Forward worth (valuation)?

Valuation information for Resonate Forward is not publicly available.

Can I buy Resonate Forward stock?

Resonate Forward shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Resonate Forward's last funding round?

Resonate Forward's most recent funding round was Grant on June 12, 2024.

Who are the main investors in Resonate Forward?

Key investors in Resonate Forward include National Institute of Neurological Disorders and Stroke (NINDS), Delaware Division of Small Business, The Michael J. Fox Foundation for Parkinson's Research, University of Delaware (Horn Entrepreneurship), National Institutes of Health (NIH).

Will Resonate Forward IPO soon?

No public IPO plans have been announced for Resonate Forward.

How can I track Resonate Forward secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Resonate Forward's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHockessin, Delaware
Employee Range1
Year Founded2016
Last FundingJun 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?